cdri 85-287 has been researched along with piperidines in 20 studies
| Studies (cdri 85-287) | Trials (cdri 85-287) | Recent Studies (post-2010) (cdri 85-287) | Studies (piperidines) | Trials (piperidines) | Recent Studies (post-2010) (piperidines) |
|---|---|---|---|---|---|
| 22 | 0 | 3 | 40,235 | 5,221 | 14,545 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (80.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dwivedi, A; Kamboj, VP; Setty, BS; Singh, MM; Sreenivasulu, S | 3 |
| Dhar, JD; Duran, S; Kapil, RS; Setty, BS | 1 |
| Durani, S; Kapil, RS; Saeed, A; Sharma, AP | 1 |
| Kamboj, VP; Setty, BS; Singh, MM; Sreenivasulu, S | 1 |
| Kamboj, VP; Singh, MM; Sreenivasulu, S | 1 |
| Dhar, JD; Dwivedi, A; Setty, BS; Srivastava, A | 1 |
| Blair, HC; Jordan, SE; McDonald, JM; McKenna, MA; Radding, W; Williams, JP | 1 |
| Gupta, RC; Lal, J | 1 |
| Bansode, FW; Dhar, JD; Gupta, S; Setty, BS | 1 |
| Dhar, JD; Mishra, R; Setty, BS | 1 |
| Bansode, FW; Chowdhury, SR; Dhar, JD; Dwivedi, A; Gupta, S; Setty, BS | 1 |
| Bansode, FW; Dhar, JD; Dwivedi, A; Setty, BS | 1 |
| Dhar, JD; Dwivedi, A; Gupta, G; Keshri, G | 1 |
| Dhar, JD; Dwivedy, A; Hajela, K; Maulik, PR; Pandey, J; Sarkhel, S; Velumurugan, D | 1 |
| Arshad, M; Ghosh, R; Sawlani, V; Sengupta, S; Sharma, S; Singh, MM | 1 |
| Dalela, D; Gupta, G; Jain, A; Jain, RK; Kumar, R; Maikhuri, JP; Sarswat, A; Sharma, VL; Verma, V | 1 |
| Chandra, V; Debnath, U; Dwivedi, A; Hajela, K; Konwar, R; Kumar, S; Manohar, M; Megu, K; Prabhakar, YS; Roy, BG; Saini, KS; Saxena, R | 1 |
| Blesson, CS; Chandra, V; Dwivedi, A; Fatima, I; Hajela, K; Hussain, MK; Kharkwal, G; Roy, BG; Saxena, R | 1 |
20 other study(ies) available for cdri 85-287 and piperidines
| Article | Year |
|---|---|
Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent.
Topics: Administration, Oral; Animals; Benzopyrans; Cell Nucleus; Cytoplasm; Estradiol; Estrogen Antagonists; Female; Ovariectomy; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Uterus | 1992 |
CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
Topics: Animals; Benzopyrans; Binding Sites; Binding, Competitive; Cytosol; Estradiol; Estrogen Antagonists; Female; Kinetics; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Uterus | 1992 |
CDRI-85/287, a novel antiestrogen and antiimplantation agent: biological profile and interaction with the estrogen receptors in immature rat uterus.
Topics: Animals; Benzopyrans; Cell Nucleus; Corpus Luteum; Cytosol; Diethylstilbestrol; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Organ Size; Ovariectomy; Piperidines; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Estrogen; Sexual Maturation; Uterus | 1992 |
Biological profile of 2-[4-(2-N-piperidinoethoxy) phenyl]-3-phenyl (2H) benzo (b) pyran--a potent antiimplantation agent in rat.
Topics: Animals; Benzopyrans; Contraceptives, Postcoital; Dose-Response Relationship, Drug; Embryo Implantation; Estrogen Antagonists; Female; Piperidines; Pregnancy; Rabbits; Rats; Rats, Inbred Strains | 1991 |
Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
Topics: Animals; Benzopyrans; Binding, Competitive; Chemical Phenomena; Chemistry; Cytosol; Estrogen Antagonists; Female; Mice; Microsomes, Liver; Molecular Structure; Organ Size; Piperidines; Pyrrolidines; Rats; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Thiophenes; Uterus | 1990 |
Effect of a pure nonsteroidal antiestrogen, CDRI-85/287, on implantation--associated histological and biochemical changes in the rat uterus.
Topics: Alkaline Phosphatase; Animals; Benzopyrans; Capillary Permeability; Decidua; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Organ Size; Phospholipids; Piperidines; Pregnancy; Proteins; Pseudopregnancy; Rats; Rats, Sprague-Dawley; RNA; Uterus | 1993 |
Effect of a new anti-oestrogen and anti-implantation agent, CDRI-85/287, on tubal transport, development and viability of rat embryos.
Topics: Animals; Benzopyrans; Blastocyst; Contraceptives, Postcoital, Hormonal; Embryo Implantation; Embryo Transfer; Embryonic and Fetal Development; Estrogen Antagonists; Female; Fetal Viability; Ovum Transport; Piperidines; Rats; Rats, Sprague-Dawley | 1994 |
Structure activity relationship of some 2,3-diaryl-2H-1-benzopyrans to their anti-implantation, estrogenic and antiestrogenic activities in rat.
Topics: Animals; Benzopyrans; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Molecular Structure; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Structure-Activity Relationship; Vagina | 1994 |
Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding.
Topics: Animals; Anticarcinogenic Agents; Benzopyrans; Bone Resorption; Calmodulin; Centchroman; Cyclic Nucleotide Phosphodiesterases, Type 1; Dose-Response Relationship, Drug; Female; Osteoclasts; Phosphoric Diester Hydrolases; Piperidines; Proton-Translocating ATPases; Tamoxifen; Trifluoperazine | 1997 |
Liquid chromatographic determination of a non-steroidal oral contraceptive CDRI-85/287 in rat serum.
Topics: Analysis of Variance; Animals; Benzopyrans; Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Estrogen Antagonists; Piperidines; Rats | 1998 |
Effect of CDRI-85/287, a potent antiimplantation agent on uterine endometrial dimensions and peroxidase levels in rat.
Topics: Animals; Benzopyrans; Embryo Implantation; Endometrium; Estrogen Antagonists; Female; Peroxidases; Piperidines; Pregnancy; Rats; Rats, Sprague-Dawley | 1998 |
Estrogen, androgen and antiestrogen responses in the accessory organs of male rats during different phases of life.
Topics: Animals; Benzopyrans; Centchroman; Dihydrotestosterone; Epididymis; Estradiol; Estrogen Antagonists; Genitalia, Male; Glycerylphosphorylcholine; Male; N-Acetylneuraminic Acid; Orchiectomy; Organ Size; Piperidines; Prostate; Rats; Rats, Sprague-Dawley; Seminal Vesicles; Sexual Maturation | 1998 |
Effect of CDRI-85/287 on uterine estradiol and progesterone receptor levels/morphometric measurements during preimplantation period in rat.
Topics: Animals; Benzopyrans; Binding Sites; Cell Size; Cytosol; Embryonic Development; Eosinophils; Epithelial Cells; Estradiol; Estrogen Antagonists; Female; Male; Mesothelin; Mitosis; Nuclear Proteins; Piperidines; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Estradiol; Receptors, Progesterone; Uterus | 1998 |
Endometrial steroid receptors during decidualization in rhesus monkey (Macaca mulatta); their modulation by anti-oestrogen CDRI-85/287.
Topics: Animals; Benzopyrans; Contraceptives, Oral, Synthetic; Decidua; Endometrium; Estrogen Antagonists; Female; Macaca mulatta; Ovariectomy; Piperidines; Pregnancy; Receptors, Steroid | 1999 |
Changes in uterine ornithine decarboxylase activity and steroid receptor levels during decidualization in the rat induced by CDRI-85/287.
Topics: Animals; Benzopyrans; Decidua; Estrogen Antagonists; Female; Ornithine Decarboxylase; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Uterus | 1999 |
Resolution, molecular structure and biological activities of the D- and L-enantiomers of potent anti-implantation agent, DL-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran.
Topics: Animals; Benzopyrans; Embryo Implantation; Estrogen Antagonists; Female; Male; Models, Molecular; Molecular Structure; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Stereoisomerism; Uterus | 1999 |
In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
Topics: Animals; Autopsy; Benzopyrans; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Calcium; Centchroman; Chick Embryo; Densitometry; Disease Models, Animal; Epithelial Cells; Ethinyl Estradiol; Female; Femur; Osteocalcin; Osteoporosis; Ovary; Parathyroid Hormone; Piperidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Tibia | 2004 |
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
Topics: 5-alpha Reductase Inhibitors; Animals; Apoptosis; Aromatase; Benzopyrans; Cell Proliferation; Cell Survival; Cells, Cultured; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Finasteride; Gene Expression Regulation; Humans; Male; Piperidines; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Androgen; RNA, Messenger; Selective Estrogen Receptor Modulators; Signal Transduction; Stromal Cells; Tamoxifen; Testosterone; Tissue Culture Techniques | 2012 |
Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.
Topics: Aged; Animals; Antineoplastic Agents; Benzopyrans; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Middle Aged; Molecular Docking Simulation; Piperidines; Signal Transduction; Xenograft Model Antitumor Assays | 2013 |
Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; Binding, Competitive; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D1; Epidermal Growth Factor; ErbB Receptors; Estrogen Receptor alpha; Estrogen Receptor beta; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; MCF-7 Cells; Mice; Phosphatidylinositol 3-Kinases; Piperidines; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Signal Transduction; Transcription Factor AP-1; Transcriptional Activation; Xenograft Model Antitumor Assays | 2013 |